EGFR and glioblastoma: Therefore, we concluded that suppressing KDELC2 downregulates glioblastoma angiogenesis by decreasing the production of IL-1β and IL-6 tumor cells, but the above two interleukins secreted by the THP-1-M1 macrophages could inhibit FGF and EGFR expression.